200,000+ products from a single source!
sales@angenechem.com
158985-00-3 | 1H-Pyrrolo[2,3-b]pyridine, 3-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-
CAS No: 158985-00-3 Catalog No: AG001R30 MDL No:
Product Description
Catalog Number:
AG001R30
Chemical Name:
1H-Pyrrolo[2,3-b]pyridine, 3-[[4-(4-chlorophenyl)-1-piperazinyl]methyl]-
CAS Number:
158985-00-3
Molecular Formula:
C18H19ClN4
Molecular Weight:
326.8233
IUPAC Name:
3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine
InChI:
InChI=1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)
InChI Key:
OGJGQVFWEPNYSB-UHFFFAOYSA-N
SMILES:
Clc1ccc(cc1)N1CCN(CC1)Cc1c[nH]c2c1cccn2
UNII:
J3OLN3XSX7
Properties
Complexity:
377
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
326.13g/mol
Formal Charge:
0
Heavy Atom Count:
23
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
326.828g/mol
Monoisotopic Mass:
326.13g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
35.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.4
Literature
| Title | Journal |
|---|---|
| L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. | The Journal of pharmacology and experimental therapeutics 20120801 |
| Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201 |
| Bromocriptine methylate suppresses glial inflammation and moderates disease progression in a mouse model of amyotrophic lateral sclerosis. | Experimental neurology 20111101 |
| Effect of acute and continuous morphine treatment on transcription factor expression in subregions of the rat caudate putamen. Marked modulation by D4 receptor activation. | Brain research 20110817 |
| p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission. | Behavioural brain research 20101225 |
| Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. | European heart journal 20100701 |
| D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD. | Neurobiology of disease 20100101 |
| Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. | Nature chemical biology 20090901 |
| Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases. | Bioorganic & medicinal chemistry 20090701 |
| Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups. | Bioorganic & medicinal chemistry 20090215 |
| Dopaminergic modulation of risk-based decision making. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201 |
| Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090201 |
| A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice. | Experimental neurology 20080601 |
| Dopamine D(4) receptor activation decreases the expression of mu-opioid receptors in the rat striatum. | The Journal of comparative neurology 20070520 |
| Stimulation of dopamine receptors in the paraventricular nucleus of the hypothalamus of male rats induces penile erection and increases extra-cellular dopamine in the nucleus accumbens: Involvement of central oxytocin. | Neuropharmacology 20070301 |
| Structure-selectivity investigations of D2-like receptor ligands by CoMFA and CoMSIA guiding the discovery of D3 selective PET radioligands. | Journal of medicinal chemistry 20070208 |
| Control of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine receptors. | Journal of neurophysiology 20061201 |
| PIP3EA and PD-168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain. | The European journal of neuroscience 20061001 |
| 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist. | Journal of medicinal chemistry 20060629 |
| Clozapine modulates aromatic L-amino acid decarboxylase activity in mouse striatum. | The Journal of pharmacology and experimental therapeutics 20060501 |
| Involvement of dopamine D3 and D4 receptors in the discriminative stimulus properties of cocaine in the rat. | Methods and findings in experimental and clinical pharmacology 20051101 |
| A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20050701 |
| 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist. | Neuropharmacology 20050701 |
| The combination of nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex. | The international journal of neuropsychopharmacology 20050601 |
| Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus. | Hippocampus 20050101 |
| Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice. | Annals of the New York Academy of Sciences 20041001 |
| Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus. | European journal of pharmacology 20040913 |
| Regulation of working memory by dopamine D4 receptor in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20040901 |
| Dopamine D4 ligands and models of receptor activation: 2-(4-pyridin-2-ylpiperazin-1-ylmethyl)-1H-benzimidazole and related heteroarylmethylarylpiperazines exhibit a substituent effect responsible for additional efficacy tuning. | Journal of medicinal chemistry 20040422 |
| Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice. | Behavioural brain research 20030616 |
| Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina. | Neuropharmacology 20030601 |
| Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors. | Neuropharmacology 20030601 |
| L-745,870 suppresses the nighttime serotonin N-acetyltransferase activity in chick retina: in vivo evidence for agonist activity at D4-dopamine receptors. | Journal of neural transmission (Vienna, Austria : 1996) 20030301 |
| Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021101 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Di- and trisubstituted pyrazolo[1,5-a]pyridine derivatives: synthesis, dopamine receptor binding and ligand efficacy. | Bioorganic & medicinal chemistry letters 20020225 |
| Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands. | Bioorganic & medicinal chemistry letters 20010604 |
| Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine. | Journal of medicinal chemistry 20010412 |
| Current and novel approaches to the drug treatment of schizophrenia. | Journal of medicinal chemistry 20010215 |
| Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats. | Neurourology and urodynamics 20010101 |
| Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. | The Journal of pharmacology and experimental therapeutics 19971101 |
| 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4 receptor. | Journal of medicinal chemistry 19960510 |
Related Products
© 2019 Angene International Limited. All rights Reserved.